Stockreport

Multiple Abstracts Highlighting Vir Biotechnology's Latest Hepatitis Delta & B Data Accepted for Presentation at the EASL Congress 2024 [Yahoo! Finance]

Vir Biotechnology, Inc.  (VIR) 
PDF SAN FRANCISCO, May 22, 2024 BUSINESS WIRE )--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that three abstracts highlighting new data from the Company's chronic [Read more]